Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 230

1.

Quinolinic acid in tumors, hemorrhage and bacterial infections of the central nervous system in children.

Heyes MP, Saito K, Milstien S, Schiff SJ.

J Neurol Sci. 1995 Nov;133(1-2):112-8.

PMID:
8583213
[PubMed - indexed for MEDLINE]
2.

A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.

Heyes MP, Saito K, Major EO, Milstien S, Markey SP, Vickers JH.

Brain. 1993 Dec;116 ( Pt 6):1425-50.

PMID:
8293279
[PubMed - indexed for MEDLINE]
3.

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

Heyes MP, Saito K, Crowley JS, Davis LE, Demitrack MA, Der M, Dilling LA, Elia J, Kruesi MJ, Lackner A, et al.

Brain. 1992 Oct;115 ( Pt 5):1249-73.

PMID:
1422788
[PubMed - indexed for MEDLINE]
4.

Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.

Heyes MP, Brew BJ, Saito K, Quearry BJ, Price RW, Lee K, Bhalla RB, Der M, Markey SP.

J Neuroimmunol. 1992 Sep;40(1):71-80.

PMID:
1387655
[PubMed - indexed for MEDLINE]
5.

Relationship of neurologic status in macaques infected with the simian immunodeficiency virus to cerebrospinal fluid quinolinic acid and kynurenic acid.

Heyes MP, Jordan EK, Lee K, Saito K, Frank JA, Snoy PJ, Markey SP, Gravell M.

Brain Res. 1992 Jan 20;570(1-2):237-50.

PMID:
1535532
[PubMed - indexed for MEDLINE]
6.

Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.

Saito K, Nowak TS Jr, Markey SP, Heyes MP.

J Neurochem. 1993 Jan;60(1):180-92.

PMID:
8417138
[PubMed - indexed for MEDLINE]
7.

Mechanism of increases in L-kynurenine and quinolinic acid in renal insufficiency.

Saito K, Fujigaki S, Heyes MP, Shibata K, Takemura M, Fujii H, Wada H, Noma A, Seishima M.

Am J Physiol Renal Physiol. 2000 Sep;279(3):F565-72.

PMID:
10966936
[PubMed - indexed for MEDLINE]
Free Article
8.

[Cerebrospinal fluid neopterin levels in children with neurologic diseases].

Nakazawa T.

No To Hattatsu. 1996 Jul;28(4):291-8. Japanese.

PMID:
8753127
[PubMed - indexed for MEDLINE]
9.

Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.

Saito K, Nowak TS Jr, Suyama K, Quearry BJ, Saito M, Crowley JS, Markey SP, Heyes MP.

J Neurochem. 1993 Dec;61(6):2061-70.

PMID:
8245962
[PubMed - indexed for MEDLINE]
10.

Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice.

Saito K, Markey SP, Heyes MP.

Brain Res. 1991 Apr 12;546(1):151-4.

PMID:
1830237
[PubMed - indexed for MEDLINE]
11.

[Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].

Saito K.

Rinsho Byori. 1995 Sep;43(9):891-901. Review. Japanese.

PMID:
7474452
[PubMed - indexed for MEDLINE]
12.

Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation.

Dale RC, Brilot F, Fagan E, Earl J.

Dev Med Child Neurol. 2009 Apr;51(4):317-23. doi: 10.1111/j.1469-8749.2008.03225.x. Epub 2009 Jan 26.

PMID:
19191826
[PubMed - indexed for MEDLINE]
13.

A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.

Saito K, Crowley JS, Markey SP, Heyes MP.

J Biol Chem. 1993 Jul 25;268(21):15496-503.

PMID:
8340378
[PubMed - indexed for MEDLINE]
Free Article
14.

The kynurenine pathway and inflammation in amyotrophic lateral sclerosis.

Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, Grant R, Brew BJ, Guillemin GJ.

Neurotox Res. 2010 Aug;18(2):132-42. doi: 10.1007/s12640-009-9129-7. Epub 2009 Nov 18.

PMID:
19921535
[PubMed - indexed for MEDLINE]
15.

Quinolinic acid in children with congenital hyperammonemia.

Batshaw ML, Robinson MB, Hyland K, Djali S, Heyes MP.

Ann Neurol. 1993 Nov;34(5):676-81.

PMID:
7694541
[PubMed - indexed for MEDLINE]
16.

Quinolinic acid accumulation and functional deficits following experimental spinal cord injury.

Blight AR, Cohen TI, Saito K, Heyes MP.

Brain. 1995 Jun;118 ( Pt 3):735-52.

PMID:
7600090
[PubMed - indexed for MEDLINE]
17.

Neopterin, biopterin, and nitric oxide concentrations in the cerebrospinal fluid of children with central nervous system infections.

Azumagawa K, Suzuki S, Tanabe T, Wakamiya E, Kawamura N, Tamai H.

Brain Dev. 2003 Apr;25(3):200-2.

PMID:
12689700
[PubMed - indexed for MEDLINE]
18.

Neuroactive kynurenines in Lyme borreliosis.

Halperin JJ, Heyes MP.

Neurology. 1992 Jan;42(1):43-50.

PMID:
1531156
[PubMed - indexed for MEDLINE]
19.

CSF quinolinic acid levels are determined by local HIV infection: cross-sectional analysis and modelling of dynamics following antiretroviral therapy.

Valle M, Price RW, Nilsson A, Heyes M, Verotta D.

Brain. 2004 May;127(Pt 5):1047-60. Epub 2004 Mar 10.

PMID:
15013955
[PubMed - indexed for MEDLINE]
Free Article
20.

Cerebrospinal fluid neopterin concentrations in central nervous system infection.

Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D.

J Infect Dis. 1993 Nov;168(5):1285-8.

PMID:
8228365
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk